6.83

6.18% -0.45

Anteris Technologies Global Corp (AVR)

Overview News Price History Discussions Forecast

Anteris Technologies Global Corp stock is traded at $6.83, with a volume of 64,218. It is down -6.18% in the last 24 hours and down -12.88% over the past month. Anteris Technologies Global Corp. is a structural heart company committed to discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. Its product, the DurAVR THV system, represents a product opportunity in a new THV class of single-piece heart valves, for the treatment of aortic stenosis. Its DurAVR THV system consists of a single-piece, biomimetic valve made with its proprietary ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold.

Previous Close:

$7.28

Open:

$7.04

24h Volume:

64,218

Relative Volume:

0.55

Market Cap:

$245.47M

Revenue:

Net Income/Loss:

P/E Ratio:

-3.4523

EPS:

-1.9784

Net Cash Flow:

1W Performance:

-13.43%

1M Performance:

-12.88%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$6.50

$7.41

1-Week Range:

$6.50

$8.08

52-Week Range:

$5.25

$8.79

Anteris Technologies Global Corp Stock (AVR) Company Profile

Name

Anteris Technologies Global Corp

Sector

Healthcare (1169)

Industry

Medical Instruments & Supplies (62)

Phone

651-493-0606

Address

860 BLUE GENTIAN ROAD, EAGAN

Employee

Twitter

Next Earnings Date

Latest SEC Filings

AVR's Discussions on Twitter

Compare AVR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AVR Anteris Technologies Global Corp	6.83	245.47M	0	0	0	-1.9784
ISRG Intuitive Surgical Inc	476.78	170.05B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	222.79	63.97B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	86.81	42.94B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	219.72	32.28B	4.93B	1.25B	1.38B	8.47
BAX Baxter International Inc	34.55	17.64B	17.28B	108.00M	391.00M	0.20

Anteris Technologies Global Corp Stock (AVR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-25	Initiated	Lake Street	Buy
Jan-07-25	Initiated	Barclays	Overweight
Jan-07-25	Initiated	Cantor Fitzgerald	Overweight
Jan-07-25	Initiated	TD Cowen	Buy

Anteris Technologies Global Corp Stock (AVR) Latest News

Mar 13, 2025

Anteris Technologies reports annual financial results By Investing.com - Investing.com South Africa

Mar 13, 2025

Anteris Technologies reports annual financial results - Investing.com

Mar 13, 2025

Anteris Technologies: A Trailblazing Year of Innovation and Expansion - kondorexp.co.il

Mar 13, 2025

Mar 12, 2025

The morning catch up: ASX to reverse losses despite war of words over tariffs - Proactive financial news

Mar 12, 2025

Anteris Reports 2024 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 12, 2025

Anteris Reports 2024 Financial Results and Provides Corporate Update - GlobeNewswire Inc.

Mar 12, 2025

Anteris Technologies: A Transformational Leap with Its Nasdaq Debut and Heart Valve Breakthroughs - kondorexp.co.il

Mar 12, 2025

Proactive financial news: fast, accessible, and actionable articles and videos for the global investment audience. - Proactive Investors Australia

Mar 12, 2025

Anteris Technologies 2024 financials strong following Nasdaq debut, with plans for heart valve pivotal trial this year - Proactive Investors Australia

Mar 12, 2025

Anteris Technologies Reports 2024 Financial Results and Advances Heart Valve Innovations - TipRanks

Mar 12, 2025

Anteris Technologies Reports Increased Losses Amid Strategic Reorganization - TipRanks

Mar 12, 2025